“Inhibition of osteoclastogenesis and inflammation by phosvitin and phosvitin hydrolysate via NF-κB and MAPK pathways in RAW 264.7 cells”, JFB, vol. 13, Mar. 2021, doi: 10.31665/JFB.2020.13261.